FCR/BR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FCR/BR, covering 2022-03-31 to 2022-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Zanubrutinib Followed Zanubrutinib Plus FCR / BR in Newly Diagnosed Symptomatic CLL/SLL [Phase 2]